StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$96.80−3.93 (-3.90%)

Close on Nov 17, 2026Market cap $6.08BP/E –Yield –

Kodiak Sciences cash

Cash and short-term investments held at the end of each period.

Kodiak Sciences's cash was $125.90M at Jun 30, 2026. For fiscal 2025 it was $209.86M, up 24.9% from the year before. The highest annual figure on record is $968.97M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$209.86M+24.9%
FY2024Dec 31, 2024$168.07M-41.1%
FY2023Dec 31, 2023$285.51M-40.4%
FY2022Dec 31, 2022$478.93M-34.5%
FY2021Dec 31, 2021$731.51M-24.5%
FY2020Dec 31, 2020$968.97M+188.0%
FY2019Dec 31, 2019$336.48M+281.3%
FY2018Dec 31, 2018$88.25M+6226.5%
FY2017Dec 31, 2017$1.40M-85.5%
FY2016Dec 31, 2016$9.62M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$125.90M+20.9%
Q1 FY2026Mar 31, 2026$169.53M+22.1%
Q4 FY2025Dec 31, 2025$209.86M+24.9%
Q3 FY2025Sep 30, 2025$72.04M-63.6%
Q2 FY2025Jun 30, 2025$104.17M-52.5%
Q1 FY2025Mar 31, 2025$138.85M-43.5%
Q4 FY2024Dec 31, 2024$168.07M-41.1%
Q3 FY2024Sep 30, 2024$197.86M-42.8%
Q2 FY2024Jun 30, 2024$219.23M-42.1%
Q1 FY2024Mar 31, 2024$245.92M-41.6%
Q4 FY2023Dec 31, 2023$285.51M-40.4%
Q3 FY2023Sep 30, 2023$345.67M-35.7%
Q2 FY2023Jun 30, 2023$378.67M-36.7%
Q1 FY2023Mar 31, 2023$421.19M-37.3%
Q4 FY2022Dec 31, 2022$478.93M-34.5%
Q3 FY2022Sep 30, 2022$537.40M-32.8%
Q2 FY2022Jun 30, 2022$597.88M-32.1%
Q1 FY2022Mar 31, 2022$671.73M-27.7%
Q4 FY2021Dec 31, 2021$731.51M-24.5%
Q3 FY2021Sep 30, 2021$799.20M+110.0%
Q2 FY2021Jun 30, 2021$880.90M+111.2%
Q1 FY2021Mar 31, 2021$929.00M+115.8%
Q4 FY2020Dec 31, 2020$968.97M+188.0%
Q3 FY2020Sep 30, 2020$380.50M+527.9%
Q2 FY2020Jun 30, 2020$417.10M+512.5%
Q1 FY2020Mar 31, 2020$430.40M+430.9%
Q4 FY2019Dec 31, 2019$336.48M+281.3%
Q3 FY2019Sep 30, 2019$60.60M+422.9%
Q2 FY2019Jun 30, 2019$68.10M+286.0%
Q1 FY2019Mar 31, 2019$81.08M+255.4%
Q4 FY2018Dec 31, 2018$88.25M+6226.5%
Q3 FY2018Sep 30, 2018$11.59M+81.3%
Q2 FY2018Jun 30, 2018$17.64M+83.3%
Q1 FY2018Mar 31, 2018$22.81M–
Q4 FY2017Dec 31, 2017$1.40M–
Q3 FY2017Sep 30, 2017$6.39M–
Q4 FY2016Dec 31, 2016$9.62M–

More Kodiak Sciences figures

See a number that looks wrong?